• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/36

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

36 Cards in this Set

  • Front
  • Back

Risk factors for SAH

hypertension, smoking, family history, cocaine use

aneurysms that have higher risk of rupture

larger (>7mm), located in posterior circulation, on the Pcomm

is there a familial clustering of SAH?

yes, first degree relatives of SAH patients = 3x more likely to suffer from SAH compared to general population

connective tissue disorders associated with intracranial aneurysms

Ehlers-Danlos syndrome


NF1


Marfan's


ADPKD (most convincing)

what are perimesencephalic hemorrhages

10% of SAH


2/3s of angio NEG SAH


blood predominantly located in perimesencephalic and prepontine cisterns

typical clinical picture of perimesencephalic hemorrhages

>50y/o, less severe neuro symptoms, rare seizures or focal deficits

why is it important to distinguish perimesencephalic hemorrhages from other aneurysmal SAH?

rebleeding and DCI related to vasospasm is extremely unusual

most common cause of non-aneurysmal SAH

head traum

how can one differentiate traumatic and nontraumatic SAH based on the CT?

Usually traumatic SAH has a thin layer of blood in the subarachnoid space around cerebral convexities or within Sylvian fissure; less common to see blood in basal cisterns or surrounding circle of Willis due to trauma (suspect aSAH)

aside from aneursymal and traumatic causes of SAH, are there other causes of SAH?

dural AV fistulas, septic / mycotic aneurysms, pituitary apoplexy, Moya moya disease, cocaine or stimulant abuse, cerebral vasculitis

CN III palsy in an otherwise healthy individual

Pcomm aneurysm

CN sign of elevated ICP

CN VI palsy

sensitivity of CT relative to onset of symptoms

Sn 100% within first 6 hours of onset of hemorrhage


85% at 5 days


50% at 1 week

What to do with NEG angio SAH?

10-20% will have negative angio


if not perimesencaphalic or if high suspicion, repeat angio


as to when? still controversial - 1 week to 3 months?

when should LP be done after SAH?

ideally delay for 6-12 hours after onset of symptoms

these findings on CT are strongly associated with development of DCI

thick cisternal clot


IVH

what is the most important prevention strategy for prevention of rebleeding in SAH

to treat and secure the aneuryms as early as possible

when should surgical clipping of aneurysms be done?

early clipping within first 3d preferred to reduce rate of rebleeding and to avoid surgery within peak of DCI

trial that compared clipping to coiling

ISAT (international subarachnoid aneurysm trial) - found favorable outcome in certain subgroups of patients treated with endovascular coiling

define vasospasm

radiographic narrowing of cerebral arteries following aSAH

incidence of vasospasm

70%

define DCI

delayed cerebral ischemia - neuro deterioration related to cerebral ischemia

incidence of DCI

20-30% of aSAH patients

mechanism of DCI

oxyhemoglobin in subarachnoid space - production of superoxide free radicals - inactivates / decreases production of NO - increases intracellular calcium - prolonged sm muscle contraction - narrowing of vessel lumen

TCD mean blood flow velocity threshold

<120 = absence of vasospasm; >200 presence of vasospasm

Methods to screen for cerebral vasospasm

frequent serial neuro assessment; TCD; CT angio; CT perf, Xenon CT, MRI with perfusion and DWI, PbtO2, direct CBF monitoring, cerebral microdialysis, continuous EEG

triple H therapy

HTN, hypervolemia, hemodilution

complications of triple H therapy

pulmonary edema, MI, hyponatremia, cerebral hyperemia and hemorrhage

components of the Triple H therapy which remain a mainstay of treatment in symptomatic vasospasm

induced HTN and volume expansion

nimodipine dose

60mg q4h x 21d

why is nimodipine given in SAH?

reduces risk of poor outcome and secondary ischemia

gold standard for evaluation of vasospasm

cath angio - allows for endovascular treatment with angioplasty or localized IA infusion of vasodilators

types of HCP in SAH

acute due to obstruction of flow in ventricular system and late due to impairment of arachnoid granulations resulting in poor CSF reabsorption

treatment of HCP in SAH

acute may need EVD; late may need VPS

what causes the pupillary changes and downward deviation of eyes in SAH with acute HCP?

dilatation of cerebral aqueduct

risk factors for seizures after SAH

older age, surgical aneurysm treatment, IPH, ant circulation aneurysms